Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype

Authors :: Shahmanesh, Mohsen
Jaleel, Henna
DeSilva, Yassus
Ross, Jonathan D C
Caslake, Muriel
Cramb, Robert
Source :: Sexually Transmitted Infections. August, 2001, Vol. 77 Issue 4, 283
Publication Year :: 2001
Abstract: Objective: To determine the prevalence of type III hyperlipoproteinaemia in a cohort of HIV infected patients taking protease inhibitors and its correlation with the apolipoprotein-E2 isoform. Design: Gross sectional study [...]

Subjects :: Prevalence studies (Epidemiology) -- Analysis
Hyperlipidemia -- Demographic aspects -- Complications and side effects
HIV infection -- Complications and side effects
Health

Tools